 | • レポートコード：B-GIR09D0660 • 出版社/出版日：GlobalInfoResearch / 2019年9月4日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ブデソニド吸入器の世界市場について調べ、まとめました。種類別セグメントは、乾燥粉末、懸濁液、スプレー等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。ブデソニド吸入器の世界市場概観、メーカー動向、メーカー別ブデソニド吸入器シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ブデソニド吸入器の市場概観 ・ブデソニド吸入器の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ブデソニド吸入器の企業別販売動向、市場シェア、市場集中度、競争動向 ・ブデソニド吸入器の世界市場規模 ・ブデソニド吸入器の北米市場分析（アメリカ、カナダ、メキシコ等） ・ブデソニド吸入器のアメリカ市場規模推移 ・ブデソニド吸入器のカナダ市場規模推移 ・ブデソニド吸入器のメキシコ市場規模推移 ・ブデソニド吸入器のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ブデソニド吸入器のドイツ市場規模推移 ・ブデソニド吸入器のイギリス市場規模推移 ・ブデソニド吸入器のロシア市場規模推移 ・ブデソニド吸入器のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ブデソニド吸入器の日本市場規模推移 ・ブデソニド吸入器の中国市場規模推移 ・ブデソニド吸入器の韓国市場規模推移 ・ブデソニド吸入器のインド市場規模推移 ・ブデソニド吸入器の東南アジア市場規模推移 ・ブデソニド吸入器の南米市場分析（ブラジル、アルゼンチン等） ・ブデソニド吸入器の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ブデソニド吸入器の種類別分析/販売量、売上、市場シェア（乾燥粉末、懸濁液、スプレー） ・ブデソニド吸入器の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・ブデソニド吸入器の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ブデソニド吸入器の販売チャネル・代理店・貿易業者・ディーラー分析 |
Budesonide Inhaler is a corticosteroid used treat a range of breathing conditions including asthma. Corticosteroids work because they reduce swelling and irritation in the airways, making air flow easier in the lungs.
Scope of the Report:
The worldwide market for Budesonide Inhaler is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Budesonide Inhaler in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZeneca
Cosmo Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
Pfizer
Dr. Falk Pharma
Chiesi Farmaceutici
Orion Corporation
Cipla Limited
Bausch Health Companies
Takeda Pharmaceutical
Lupin Limited
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Dry Powder
Suspension
Sprays
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Budesonide Inhaler product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Budesonide Inhaler, with price, sales, revenue and global market share of Budesonide Inhaler in 2017 and 2018.
Chapter 3, the Budesonide Inhaler competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Budesonide Inhaler breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Budesonide Inhaler market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Budesonide Inhaler sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Budesonide Inhaler Introduction
1.2 Market Analysis by Type
1.2.1 Dry Powder
1.2.2 Suspension
1.2.3 Sprays
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Budesonide Inhaler Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Cosmo Pharmaceuticals
2.2.1 Business Overview
2.2.2 Budesonide Inhaler Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cosmo Pharmaceuticals Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva Pharmaceutical
2.3.1 Business Overview
2.3.2 Budesonide Inhaler Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Budesonide Inhaler Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Mylan
2.5.1 Business Overview
2.5.2 Budesonide Inhaler Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Budesonide Inhaler Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Dr. Falk Pharma
2.7.1 Business Overview
2.7.2 Budesonide Inhaler Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dr. Falk Pharma Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Chiesi Farmaceutici
2.8.1 Business Overview
2.8.2 Budesonide Inhaler Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Chiesi Farmaceutici Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Orion Corporation
2.9.1 Business Overview
2.9.2 Budesonide Inhaler Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Orion Corporation Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Cipla Limited
2.10.1 Business Overview
2.10.2 Budesonide Inhaler Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cipla Limited Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Bausch Health Companies
2.11.1 Business Overview
2.11.2 Budesonide Inhaler Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bausch Health Companies Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Takeda Pharmaceutical
2.12.1 Business Overview
2.12.2 Budesonide Inhaler Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Takeda Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Lupin Limited
2.13.1 Business Overview
2.13.2 Budesonide Inhaler Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Lupin Limited Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Synmosa Biopharma Corporation
2.14.1 Business Overview
2.14.2 Budesonide Inhaler Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Synmosa Biopharma Corporation Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Lunan Better Pharmaceutical
2.15.1 Business Overview
2.15.2 Budesonide Inhaler Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Lunan Better Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Shanghai Sine Pharmaceutical Laboratories
2.16.1 Business Overview
2.16.2 Budesonide Inhaler Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Budesonide Inhaler Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Budesonide Inhaler Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Budesonide Inhaler Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Budesonide Inhaler Manufacturer Market Share in 2018
3.3.2 Top 6 Budesonide Inhaler Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Budesonide Inhaler Market Analysis by Regions
4.1 Global Budesonide Inhaler Sales, Revenue and Market Share by Regions
4.1.1 Global Budesonide Inhaler Sales and Market Share by Regions (2014-2019)
4.1.2 Global Budesonide Inhaler Revenue and Market Share by Regions (2014-2019)
4.2 North America Budesonide Inhaler Sales and Growth Rate (2014-2019)
4.3 Europe Budesonide Inhaler Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Budesonide Inhaler Sales and Growth Rate (2014-2019)
4.5 South America Budesonide Inhaler Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Budesonide Inhaler Sales and Growth Rate (2014-2019)
5 North America Budesonide Inhaler by Country
5.1 North America Budesonide Inhaler Sales, Revenue and Market Share by Country
5.1.1 North America Budesonide Inhaler Sales and Market Share by Country (2014-2019)
5.1.2 North America Budesonide Inhaler Revenue and Market Share by Country (2014-2019)
5.2 United States Budesonide Inhaler Sales and Growth Rate (2014-2019)
5.3 Canada Budesonide Inhaler Sales and Growth Rate (2014-2019)
5.4 Mexico Budesonide Inhaler Sales and Growth Rate (2014-2019)
6 Europe Budesonide Inhaler by Country
6.1 Europe Budesonide Inhaler Sales, Revenue and Market Share by Country
6.1.1 Europe Budesonide Inhaler Sales and Market Share by Country (2014-2019)
6.1.2 Europe Budesonide Inhaler Revenue and Market Share by Country (2014-2019)
6.2 Germany Budesonide Inhaler Sales and Growth Rate (2014-2019)
6.3 UK Budesonide Inhaler Sales and Growth Rate (2014-2019)
6.4 France Budesonide Inhaler Sales and Growth Rate (2014-2019)
6.5 Russia Budesonide Inhaler Sales and Growth Rate (2014-2019)
6.6 Italy Budesonide Inhaler Sales and Growth Rate (2014-2019)
7 Asia-Pacific Budesonide Inhaler by Country
7.1 Asia-Pacific Budesonide Inhaler Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Budesonide Inhaler Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Budesonide Inhaler Revenue and Market Share by Country (2014-2019)
7.2 China Budesonide Inhaler Sales and Growth Rate (2014-2019)
7.3 Japan Budesonide Inhaler Sales and Growth Rate (2014-2019)
7.4 Korea Budesonide Inhaler Sales and Growth Rate (2014-2019)
7.5 India Budesonide Inhaler Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Budesonide Inhaler Sales and Growth Rate (2014-2019)
8 South America Budesonide Inhaler by Country
8.1 South America Budesonide Inhaler Sales, Revenue and Market Share by Country
8.1.1 South America Budesonide Inhaler Sales and Market Share by Country (2014-2019)
8.1.2 South America Budesonide Inhaler Revenue and Market Share by Country (2014-2019)
8.2 Brazil Budesonide Inhaler Sales and Growth Rate (2014-2019)
8.3 Argentina Budesonide Inhaler Sales and Growth Rate (2014-2019)
8.4 Colombia Budesonide Inhaler Sales and Growth Rate (2014-2019)
9 Middle East and Africa Budesonide Inhaler by Countries
9.1 Middle East and Africa Budesonide Inhaler Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Budesonide Inhaler Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Budesonide Inhaler Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Budesonide Inhaler Sales and Growth Rate (2014-2019)
9.3 Turkey Budesonide Inhaler Sales and Growth Rate (2014-2019)
9.4 Egypt Budesonide Inhaler Sales and Growth Rate (2014-2019)
9.5 Nigeria Budesonide Inhaler Sales and Growth Rate (2014-2019)
9.6 South Africa Budesonide Inhaler Sales and Growth Rate (2014-2019)
10 Global Budesonide Inhaler Market Segment by Type
10.1 Global Budesonide Inhaler Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Budesonide Inhaler Sales and Market Share by Type (2014-2019)
10.1.2 Global Budesonide Inhaler Revenue and Market Share by Type (2014-2019)
10.2 Dry Powder Sales Growth and Price
10.2.1 Global Dry Powder Sales Growth (2014-2019)
10.2.2 Global Dry Powder Price (2014-2019)
10.3 Suspension Sales Growth and Price
10.3.1 Global Suspension Sales Growth (2014-2019)
10.3.2 Global Suspension Price (2014-2019)
10.4 Sprays Sales Growth and Price
10.4.1 Global Sprays Sales Growth (2014-2019)
10.4.2 Global Sprays Price (2014-2019)
11 Global Budesonide Inhaler Market Segment by Application
11.1 Global Budesonide Inhaler Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Retail Pharmacies Sales Growth (2014-2019)
11.4 Online Pharmacies Sales Growth (2014-2019)
12 Budesonide Inhaler Market Forecast (2019-2024)
12.1 Global Budesonide Inhaler Sales, Revenue and Growth Rate (2019-2024)
12.2 Budesonide Inhaler Market Forecast by Regions (2019-2024)
12.2.1 North America Budesonide Inhaler Market Forecast (2019-2024)
12.2.2 Europe Budesonide Inhaler Market Forecast (2019-2024)
12.2.3 Asia-Pacific Budesonide Inhaler Market Forecast (2019-2024)
12.2.4 South America Budesonide Inhaler Market Forecast (2019-2024)
12.2.5 Middle East and Africa Budesonide Inhaler Market Forecast (2019-2024)
12.3 Budesonide Inhaler Market Forecast by Type (2019-2024)
12.3.1 Global Budesonide Inhaler Sales Forecast by Type (2019-2024)
12.3.2 Global Budesonide Inhaler Market Share Forecast by Type (2019-2024)
12.4 Budesonide Inhaler Market Forecast by Application (2019-2024)
12.4.1 Global Budesonide Inhaler Sales Forecast by Application (2019-2024)
12.4.2 Global Budesonide Inhaler Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Budesonide Inhaler Picture
Table Product Specifications of Budesonide Inhaler
Figure Global Sales Market Share of Budesonide Inhaler by Types in 2018
Table Budesonide Inhaler Types for Major Manufacturers
Figure Dry Powder Picture
Figure Suspension Picture
Figure Sprays Picture
Figure Budesonide Inhaler Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Figure United States Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure France Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure UK Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure China Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure India Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Budesonide Inhaler Revenue (Value) and Growth Rate (2014-2024)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Budesonide Inhaler Type and Applications
Table AstraZeneca Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cosmo Pharmaceuticals Budesonide Inhaler Type and Applications
Table Cosmo Pharmaceuticals Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Budesonide Inhaler Type and Applications
Table Teva Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Budesonide Inhaler Type and Applications
Table Novartis Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Budesonide Inhaler Type and Applications
Table Mylan Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Budesonide Inhaler Type and Applications
Table Pfizer Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dr. Falk Pharma Basic Information, Manufacturing Base and Competitors
Table Dr. Falk Pharma Budesonide Inhaler Type and Applications
Table Dr. Falk Pharma Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table Chiesi Farmaceutici Budesonide Inhaler Type and Applications
Table Chiesi Farmaceutici Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Orion Corporation Basic Information, Manufacturing Base and Competitors
Table Orion Corporation Budesonide Inhaler Type and Applications
Table Orion Corporation Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Limited Basic Information, Manufacturing Base and Competitors
Table Cipla Limited Budesonide Inhaler Type and Applications
Table Cipla Limited Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Budesonide Inhaler Type and Applications
Table Bausch Health Companies Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Budesonide Inhaler Type and Applications
Table Takeda Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Lupin Limited Basic Information, Manufacturing Base and Competitors
Table Lupin Limited Budesonide Inhaler Type and Applications
Table Lupin Limited Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Synmosa Biopharma Corporation Basic Information, Manufacturing Base and Competitors
Table Synmosa Biopharma Corporation Budesonide Inhaler Type and Applications
Table Synmosa Biopharma Corporation Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Lunan Better Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Lunan Better Pharmaceutical Budesonide Inhaler Type and Applications
Table Lunan Better Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Sine Pharmaceutical Laboratories Basic Information, Manufacturing Base and Competitors
Table Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Type and Applications
Table Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Budesonide Inhaler Sales by Manufacturer (2017-2018)
Figure Global Budesonide Inhaler Sales Market Share by Manufacturer in 2017
Figure Global Budesonide Inhaler Sales Market Share by Manufacturer in 2018
Table Global Budesonide Inhaler Revenue by Manufacturer (2017-2018)
Figure Global Budesonide Inhaler Revenue Market Share by Manufacturer in 2017
Figure Global Budesonide Inhaler Revenue Market Share by Manufacturer in 2018
Figure Top 3 Budesonide Inhaler Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Budesonide Inhaler Manufacturer (Revenue) Market Share in 2018
Figure Global Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Global Budesonide Inhaler Revenue and Growth Rate (2014-2019)
Table Global Budesonide Inhaler Sales by Regions (2014-2019)
Table Global Budesonide Inhaler Sales Market Share by Regions (2014-2019)
Table Global Budesonide Inhaler Revenue by Regions (2014-2019)
Figure Global Budesonide Inhaler Revenue Market Share by Regions in 2014
Figure Global Budesonide Inhaler Revenue Market Share by Regions in 2018
Figure North America Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Europe Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure South America Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure North America Budesonide Inhaler Revenue and Growth Rate (2014-2019)
Table North America Budesonide Inhaler Sales by Countries (2014-2019)
Table North America Budesonide Inhaler Sales Market Share by Countries (2014-2019)
Figure North America Budesonide Inhaler Sales Market Share by Countries in 2014
Figure North America Budesonide Inhaler Sales Market Share by Countries in 2018
Table North America Budesonide Inhaler Revenue by Countries (2014-2019)
Table North America Budesonide Inhaler Revenue Market Share by Countries (2014-2019)
Figure North America Budesonide Inhaler Revenue Market Share by Countries in 2014
Figure North America Budesonide Inhaler Revenue Market Share by Countries in 2018
Figure United States Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Canada Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Mexico Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Europe Budesonide Inhaler Revenue and Growth Rate (2014-2019)
Table Europe Budesonide Inhaler Sales by Countries (2014-2019)
Table Europe Budesonide Inhaler Sales Market Share by Countries (2014-2019)
Table Europe Budesonide Inhaler Revenue by Countries (2014-2019)
Figure Europe Budesonide Inhaler Revenue Market Share by Countries in 2017
Figure Europe Budesonide Inhaler Revenue Market Share by Countries in 2018
Figure Germany Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure UK Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure France Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Russia Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Italy Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Budesonide Inhaler Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Budesonide Inhaler Sales by Countries (2014-2019)
Table Asia-Pacific Budesonide Inhaler Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Budesonide Inhaler Sales Market Share by Countries 2018
Table Asia-Pacific Budesonide Inhaler Revenue by Countries (2014-2019)
Figure Asia-Pacific Budesonide Inhaler Revenue Market Share by Countries 2018
Figure China Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Japan Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Korea Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure India Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Southeast Asia Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure South America Budesonide Inhaler Revenue and Growth Rate (2014-2019)
Table South America Budesonide Inhaler Sales by Countries (2014-2019)
Table South America Budesonide Inhaler Sales Market Share by Countries (2014-2019)
Figure South America Budesonide Inhaler Sales Market Share by Countries in 2018
Table South America Budesonide Inhaler Revenue by Countries (2014-2019)
Table South America Budesonide Inhaler Revenue Market Share by Countries (2014-2019)
Figure South America Budesonide Inhaler Revenue Market Share by Countries in 2018
Figure Brazil Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Argentina Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Colombia Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Budesonide Inhaler Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Budesonide Inhaler Sales by Countries (2014-2019)
Table Middle East and Africa Budesonide Inhaler Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Budesonide Inhaler Sales Market Share by Countries in 2018
Table Middle East and Africa Budesonide Inhaler Revenue by Countries (2014-2019)
Table Middle East and Africa Budesonide Inhaler Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Budesonide Inhaler Revenue Market Share by Countries in 2014
Figure Middle East and Africa Budesonide Inhaler Revenue Market Share by Countries in 2018
Figure Saudi Arabia Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure UAE Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Egypt Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure Nigeria Budesonide Inhaler Sales and Growth Rate (2014-2019)
Figure South Africa Budesonide Inhaler Sales and Growth Rate (2014-2019)
Table Global Budesonide Inhaler Sales by Type (2014-2019)
Table Global Budesonide Inhaler Sales Share by Type (2014-2019)
Table Global Budesonide Inhaler Revenue by Type (2014-2019)
Table Global Budesonide Inhaler Revenue Share by Type (2014-2019)
Figure Global Dry Powder Sales Growth (2014-2019)
Figure Global Dry Powder Price (2014-2019)
Figure Global Suspension Sales Growth (2014-2019)
Figure Global Suspension Price (2014-2019)
Figure Global Sprays Sales Growth (2014-2019)
Figure Global Sprays Price (2014-2019)
Table Global Budesonide Inhaler Sales by Application (2014-2019)
Table Global Budesonide Inhaler Sales Share by Application (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Budesonide Inhaler Sales, Revenue and Growth Rate (2019-2024)
Table Global Budesonide Inhaler Sales Forecast by Regions (2019-2024)
Table Global Budesonide Inhaler Market Share Forecast by Regions (2019-2024)
Figure North America Sales Budesonide Inhaler Market Forecast (2019-2024)
Figure Europe Sales Budesonide Inhaler Market Forecast (2019-2024)
Figure Asia-Pacific Sales Budesonide Inhaler Market Forecast (2019-2024)
Figure South America Sales Budesonide Inhaler Market Forecast (2019-2024)
Figure Middle East and Africa Sales Budesonide Inhaler Market Forecast (2019-2024)
Table Global Budesonide Inhaler Sales Forecast by Type (2019-2024)
Table Global Budesonide Inhaler Market Share Forecast by Type (2019-2024)
Table Global Budesonide Inhaler Sales Forecast by Application (2019-2024)
Table Global Budesonide Inhaler Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のめまい治療市場予測（～2024年） Vertigo is a symptom of several different health conditions such as labyrinthitis and meniere's disease. Scope of the Report: The global Vertigo Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and…- 世界のトラコーマ治療市場予測（～2024年） Trachoma is an infectious disease caused by bacterium Chlamydia trachomatis. The infection causes a roughening of the inner surface of the eyelids. Scope of the Report: The global Trachoma Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 202…
- 世界のCox-2阻害剤市場予測（～2024年） Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins. Scope of the Report: The global Cox-2 Inhibitors mar…
- 世界のポルフィリン症治療市場予測（～2024年） Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Scope of the Report: The global Porphyrias Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a …
- 世界のブリリンタ市場予測（～2024年） Brilinta is the trade name of ticagrelor, is a platelet aggregation inhibitor produced by AstraZeneca. Scope of the Report: The worldwide market for Brilinta is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, accordi…